Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women

Sudeepa Bhattacharyya, Eric R. Siegel, Sara J. Achenbach, Sundeep Khosla, Larry J. Suva

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Early diagnosis of the onset of osteoporosis is key to the delivery of effective therapy. Biochemical markers of bone turnover provide a means of evaluating skeletal dynamics that complements static measurements of BMD by DXA. Conventional clinical measurements of bone turnover, primarily the estimation of collagen and its breakdown products in the blood or urine, lack both sensitivity and specificity as a reliable diagnostic tool. As a result, improved tests are needed to augment the use of BMD measurements as the principle diagnostic modality. In this study, the serum proteome of 58 postmenopausal women with high or low/normal bone turnover (training set) was analyzed by surface enhanced laser-desorption/ionization time-of-flight mass spectrometry, and a diagnostic fingerprint was identified using a variety of statistical and machine learning tools. The diagnostic fingerprint was validated in a separate distinct test set, consisting of serum samples from an additional 59 postmenopausal women obtained from the same Mayo cohort, with a gap of 2 yr. Specific protein peaks that discriminate between postmenopausal patients with high or low/normal bone turnover were identified and validated. Multiple supervised learning approaches were able to classify the level of bone turnover in the training set with 80% sensitivity and 100% specificity. In addition, the individual protein peaks were also significantly correlated with BMD measurements in these patients. Four of the major discriminatory peaks in the diagnostic profile were identified as fragments of interalpha-trypsin-inhibitor heavy chain H4 precursor (ITIH4), a plasma kallikrein-sensitive glycoprotein that is a component of the host response system. These data suggest that these serum protein fragments are the serum-borne reflection of the increased osteoclast activity, leading to the increased bone turnover that is associated with decreasing BMD and presumably an increased risk of fracture. In conjunction with the identification of the individual proteins, this protein fingerprint may provide a novel approach to evaluate high bone turnover states.

Original languageEnglish (US)
Pages (from-to)1106-1117
Number of pages12
JournalJournal of Bone and Mineral Research
Volume23
Issue number7
DOIs
StatePublished - Jul 2008

Fingerprint

Bone Remodeling
Biomarkers
Serum
Dermatoglyphics
Plasma Kallikrein
Sensitivity and Specificity
Proteins
Peptide Mapping
Trypsin Inhibitors
Osteoclasts
Proteome
Osteoporosis
Blood Proteins
Early Diagnosis
Mass Spectrometry
Glycoproteins
Lasers
Collagen
Learning
Urine

Keywords

  • Biomarkers
  • Bone turnover
  • Fracture risk
  • Surface enhanced laser desorption/ionization time of flight mass spectrometry

ASJC Scopus subject areas

  • Surgery

Cite this

Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women. / Bhattacharyya, Sudeepa; Siegel, Eric R.; Achenbach, Sara J.; Khosla, Sundeep; Suva, Larry J.

In: Journal of Bone and Mineral Research, Vol. 23, No. 7, 07.2008, p. 1106-1117.

Research output: Contribution to journalArticle

Bhattacharyya, Sudeepa ; Siegel, Eric R. ; Achenbach, Sara J. ; Khosla, Sundeep ; Suva, Larry J. / Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women. In: Journal of Bone and Mineral Research. 2008 ; Vol. 23, No. 7. pp. 1106-1117.
@article{fb98f50a328b4cf2ab09d031f2eab70e,
title = "Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women",
abstract = "Early diagnosis of the onset of osteoporosis is key to the delivery of effective therapy. Biochemical markers of bone turnover provide a means of evaluating skeletal dynamics that complements static measurements of BMD by DXA. Conventional clinical measurements of bone turnover, primarily the estimation of collagen and its breakdown products in the blood or urine, lack both sensitivity and specificity as a reliable diagnostic tool. As a result, improved tests are needed to augment the use of BMD measurements as the principle diagnostic modality. In this study, the serum proteome of 58 postmenopausal women with high or low/normal bone turnover (training set) was analyzed by surface enhanced laser-desorption/ionization time-of-flight mass spectrometry, and a diagnostic fingerprint was identified using a variety of statistical and machine learning tools. The diagnostic fingerprint was validated in a separate distinct test set, consisting of serum samples from an additional 59 postmenopausal women obtained from the same Mayo cohort, with a gap of 2 yr. Specific protein peaks that discriminate between postmenopausal patients with high or low/normal bone turnover were identified and validated. Multiple supervised learning approaches were able to classify the level of bone turnover in the training set with 80{\%} sensitivity and 100{\%} specificity. In addition, the individual protein peaks were also significantly correlated with BMD measurements in these patients. Four of the major discriminatory peaks in the diagnostic profile were identified as fragments of interalpha-trypsin-inhibitor heavy chain H4 precursor (ITIH4), a plasma kallikrein-sensitive glycoprotein that is a component of the host response system. These data suggest that these serum protein fragments are the serum-borne reflection of the increased osteoclast activity, leading to the increased bone turnover that is associated with decreasing BMD and presumably an increased risk of fracture. In conjunction with the identification of the individual proteins, this protein fingerprint may provide a novel approach to evaluate high bone turnover states.",
keywords = "Biomarkers, Bone turnover, Fracture risk, Surface enhanced laser desorption/ionization time of flight mass spectrometry",
author = "Sudeepa Bhattacharyya and Siegel, {Eric R.} and Achenbach, {Sara J.} and Sundeep Khosla and Suva, {Larry J.}",
year = "2008",
month = "7",
doi = "10.1359/jbmr.080235",
language = "English (US)",
volume = "23",
pages = "1106--1117",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women

AU - Bhattacharyya, Sudeepa

AU - Siegel, Eric R.

AU - Achenbach, Sara J.

AU - Khosla, Sundeep

AU - Suva, Larry J.

PY - 2008/7

Y1 - 2008/7

N2 - Early diagnosis of the onset of osteoporosis is key to the delivery of effective therapy. Biochemical markers of bone turnover provide a means of evaluating skeletal dynamics that complements static measurements of BMD by DXA. Conventional clinical measurements of bone turnover, primarily the estimation of collagen and its breakdown products in the blood or urine, lack both sensitivity and specificity as a reliable diagnostic tool. As a result, improved tests are needed to augment the use of BMD measurements as the principle diagnostic modality. In this study, the serum proteome of 58 postmenopausal women with high or low/normal bone turnover (training set) was analyzed by surface enhanced laser-desorption/ionization time-of-flight mass spectrometry, and a diagnostic fingerprint was identified using a variety of statistical and machine learning tools. The diagnostic fingerprint was validated in a separate distinct test set, consisting of serum samples from an additional 59 postmenopausal women obtained from the same Mayo cohort, with a gap of 2 yr. Specific protein peaks that discriminate between postmenopausal patients with high or low/normal bone turnover were identified and validated. Multiple supervised learning approaches were able to classify the level of bone turnover in the training set with 80% sensitivity and 100% specificity. In addition, the individual protein peaks were also significantly correlated with BMD measurements in these patients. Four of the major discriminatory peaks in the diagnostic profile were identified as fragments of interalpha-trypsin-inhibitor heavy chain H4 precursor (ITIH4), a plasma kallikrein-sensitive glycoprotein that is a component of the host response system. These data suggest that these serum protein fragments are the serum-borne reflection of the increased osteoclast activity, leading to the increased bone turnover that is associated with decreasing BMD and presumably an increased risk of fracture. In conjunction with the identification of the individual proteins, this protein fingerprint may provide a novel approach to evaluate high bone turnover states.

AB - Early diagnosis of the onset of osteoporosis is key to the delivery of effective therapy. Biochemical markers of bone turnover provide a means of evaluating skeletal dynamics that complements static measurements of BMD by DXA. Conventional clinical measurements of bone turnover, primarily the estimation of collagen and its breakdown products in the blood or urine, lack both sensitivity and specificity as a reliable diagnostic tool. As a result, improved tests are needed to augment the use of BMD measurements as the principle diagnostic modality. In this study, the serum proteome of 58 postmenopausal women with high or low/normal bone turnover (training set) was analyzed by surface enhanced laser-desorption/ionization time-of-flight mass spectrometry, and a diagnostic fingerprint was identified using a variety of statistical and machine learning tools. The diagnostic fingerprint was validated in a separate distinct test set, consisting of serum samples from an additional 59 postmenopausal women obtained from the same Mayo cohort, with a gap of 2 yr. Specific protein peaks that discriminate between postmenopausal patients with high or low/normal bone turnover were identified and validated. Multiple supervised learning approaches were able to classify the level of bone turnover in the training set with 80% sensitivity and 100% specificity. In addition, the individual protein peaks were also significantly correlated with BMD measurements in these patients. Four of the major discriminatory peaks in the diagnostic profile were identified as fragments of interalpha-trypsin-inhibitor heavy chain H4 precursor (ITIH4), a plasma kallikrein-sensitive glycoprotein that is a component of the host response system. These data suggest that these serum protein fragments are the serum-borne reflection of the increased osteoclast activity, leading to the increased bone turnover that is associated with decreasing BMD and presumably an increased risk of fracture. In conjunction with the identification of the individual proteins, this protein fingerprint may provide a novel approach to evaluate high bone turnover states.

KW - Biomarkers

KW - Bone turnover

KW - Fracture risk

KW - Surface enhanced laser desorption/ionization time of flight mass spectrometry

UR - http://www.scopus.com/inward/record.url?scp=45849153982&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=45849153982&partnerID=8YFLogxK

U2 - 10.1359/jbmr.080235

DO - 10.1359/jbmr.080235

M3 - Article

C2 - 18302502

AN - SCOPUS:45849153982

VL - 23

SP - 1106

EP - 1117

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 7

ER -